MCP
ZBH icon

Meridiem Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Meridiem Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-237,950
Closed -$26.9M – 99
2025
Q1 		$26.9M Buy
237,950
+129,018
+118% +$13.8M 2.81% 13
2024
Q4 		$11.5M Buy
+108,932
New +$11.7M 1.01% 39

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meridiem Capital Partners's ZBH Position: Q2 2025 in Review

Meridiem Capital Partners sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 237,950 shares — an estimated $26.9M sold.

Meridiem Capital Partners first reported a position in ZBH in Q4 2024 and held it in 2 quarters. The position peaked at $26.9M in Q1 2025. 935 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Meridiem Capital Partners reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Meridiem Capital Partners sold 237,950 Zimmer Biomet shares in Q2 2025, an estimated $26.9M.
  • Meridiem Capital Partners first reported a position in Zimmer Biomet in Q4 2024 and held it in 2 quarters.
  • Meridiem Capital Partners's Zimmer Biomet position peaked at $26.9M in Q1 2025.
  • 935 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Meridiem Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.